Skip to content

Public FDA record

Z-1421-2020: Atellica CH Reaction Ring Segment, SMN 11099326, UDI 00630414596143

Recall record Z-1421-2020 for Siemens Healthcare Diagnostics, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1421-2020
Company in FDA record
Siemens Healthcare Diagnostics, Inc.
FDA classification date
Mar 2, 2020
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Some lots ending in "17", "18", "19", or higher may have cuvette defects allowing water from the water bath to contaminate the interior of the cuvette, which may falsely elevate or depress sample results.

Source facts

Action
The firm distributed Urgent Medical Device Correction letters to all affected customers on January 17, 2020. Customers were asked to check each Atellica CH 930 Analyzer in their laboratory as well as in their inventory for impacted cuvette lot numbers ending in "17" or "18" (6th and 7th digits). These devices must be purged from the customer's inventory. If the customer does not have enough cuvette segments of the unimpacted lot in their inventory, they may contact customer service. Detailed instructions were provided in the appendices to the customer letter. ***Updated 3/2/2020*** An updated Urgent Medical Device Correction was distributed to all customers on February 26, 2020, due to the recalling firm adding cuvette segment kit lots ending in "19" to the affected products list. The follow-up communication advises customers of the potential for falsely depressed or elevated results from Atellica CH reaction cuvette segments with the kit lot ending in "19" and above, due to a cuvette defect allowing water bath to contaminate the cuvette. Customers who routinely run the CO2_c assay will be instructed to run 300 replicates of the CO2_c calibrator on their analyzer in order to cover all cuvette positions. The customers will then follow the instructions provided in the communication and will use the mean value of the 300 replicates to determine if there is cuvette impact. If all individual calibrator results are d12% of the mean calibrator value, no further action is required, and the laboratories can continue to process patient samples. If any individual calibrator result is >12% of the mean calibrator value, customers will be asked to contact Siemens Customer Care Center to determine additional action to be taken prior to processing patient samples. Customers who do not routinely run CO2_c samples in their laboratory will be instructed to run all patient samples in duplicate for every assay except Sodium, Potassium, and Chloride. Customers will be asked t
Initiated
2020-01-12
Root cause
Under Investigation by firm
Distribution
Domestic distribution nationwide. Worldwide foreign distribution.
Recall number
Z-1421-2020
Recall status
Open, Classified
CDRH record ID
179410
FDA classified
2020-03-02
Recall event number
84788

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗